However, EGFR-independent STAT3 signalling also exists, through activation of the glycoprotein 130 (gp130) receptor family via interleukin 6 (IL-6), described for SCCHN cell lines [35]. Here, STAT3 is linked to head and neck squamous cell carcinoma.